US51654W1018
US51654W1018
Lantern Pharma Inc.
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | -- | -- | -- |
| Cost of Revenue | -- | -- | -- |
| Gross Profit | -- | -- | -- |
| 17.978.494 | 22.216.437 | 19.1% | |
| Operating Income | -17.978.494 | -22.216.437 | 19.1% |
| Pretax Income | -17.119.438 | -20.781.213 | 17.6% |
| Net Income Common Stockholders | -17.119.438 | -20.781.213 | 17.6% |
| -- | -- | -- | |
| -- | -- | -- |